Next Frontier of Cancer Research: Bispecifics, Combination Therapy and Emerging Modalities

Concurrent Events

• 02:35 PM - 03:15 PM

  Emerging Treatments

  Emerging Treatments | Neurodegenerative Diseases

  Moderators

  Jason Gerberry,

  Specialty Pharma and SMid-Cap Biotech Analyst, BofA Securities

  Jason Zemansky,

  SMid-Cap Biotech Analyst, BofA Securities

  Speakers

  James Berry, MD,

  Chief, Division of Motor Neuron Diseases; Director, MGH NCRI, Mass General Brigham;

  Associate Professor of Neurology, Harvard Medical School

  Merit Cudkowicz, MD,

  Executive Director, Neuroscience Institute, Massachusetts General Brigham;

  Julieanne Dorn Professor of Neurology, Harvard Medical School

  Howard Weiner, MD,

  Co-Director, Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital;

  Robert L. Kroc Professor of Neurology, Harvard Medical School